A
Akari Therapeutics (AKTX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Akari Therapeutics (AKTX)
Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activati... Read more
- USD1.07
- USD1.07
- USD1.01
- USD4.22
- -6.80%
- --
- 12.42k
- 25.18k
- 36M
- 0.85
- -74.90%
Stock News
5 hours ago
Elon Musk's plan to build Boring Co. tunnels in Nashville sparks partisan feud
CNBC
6 hours ago
NETGEAR, Inc. (NTGR) Q2 2025 Earnings Call Transcript
SeekingAlpha
6 hours ago
Why is Meta’s stock soaring after earnings? It’s about far more than the numbers.
MarketWatch
yesterday
Microsoft's monster quarter and strong outlook cements its status as an AI leader
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
